Audit2020: Evolving the Internal Audit Process

The internal audit profession is very similar to other professions; very resistant to change. When one of our profession’s main goals is to promote efficiency and effectiveness, we have to be more adept at adjusting and being open-minded to change. Audit2020 is a course that takes an in-depth look at the accepted practices inherent in internal audit and critically analyses each piece, identifying ways to enhance the current view and process of internal auditing.

Webinar Nov 11 2025, Tuesday 02:00 PM EDT 120 Minutes Advance Level Code: GRC0000224

I. Annual Risk Assessment    
     a. What is a Continuous Risk Assessment?
     b. Assessment modes
     c. Assessing Emerging Risk
II. Foundational Pieces of Successful Internal Audit Departments
III. Audit Cycle
     a. Audit Planning
            i. Formality of Engagement Risk Assessment
            ii. Utilizing a True Top-Down Risk-Based Approach
            iii. What should I test and why?
            iv. Building an Effective and Efficient Audit Workprogram
     b. Fieldwork
            i. Timing & Contents of PBC List
            ii. Sampling Methodology
            iii. What support to keep and why?
            iv. Presenting Observations to Clients
     c. Reporting/Wrap-Up
            i. Do We Even Need a Formal Report?
            ii. Timing of Audit Report

  • Criteria to identify key/significant controls
  • Identify the most effective controls to test
  • Understand the differences between control design and effectiveness testing
  • Learn about ways to test controls the most efficiently and effectively

Financial, Operational, and Information Technology Auditors with less than five years of audit experience (NASBA Field of Study: Auditing).

ALAN GOLDEN
ALAN GOLDEN
35 years of experience in the medical device industry, both in basic research and quality assurance.

Alan has over 35 years of experience in the medical device industry, both in basic research and quality assurance. Alan spent 31 years at Abbott Laboratories. For the first 16 years as part of diagnostics R&D, he developed recombinant proteins used in diagnostics tests, received three US patents and published numerous papers and abstracts. Alan then transitioned to a quality assurance role where in both the Abbott Diagnostics and Abbott Molecular divisions, he was responsible for quality assurance for new product development, on-market product support and operations.

  • 90 Mins | Dec 31, Wed , 01:00 PM EDT

This live interactive presentation will also discuss the regulations associated with the detection, correction, and prev...

ALAN GOLDEN By ALAN GOLDEN

  • Dec 26, Friday | 01:00 PM EDT | 75 Mins

“The future belongs to individuals and companies who embrace the entrepreneurial spirit, whether that is inside or...

  • Dec 26, Friday | 02:00 PM EDT | 120 Mins

A properly-composed JHA/AHA is one of the primary documents that large clients are increasingly asking to review in adva...

  • Dec 26, Friday | 03:00 PM EDT | 90 Mins

Skills-based hiring has been a topic of interest for many businesses and governments for the past few years. But even as...